TACC3 and glioma: By comprehensively analyzing the transcriptome, miRNA data, the pathological biomarker and clinical features, our findings suggest that TACC3 expression could reflect malignant behaviors and poor outcomes, which are indicative of a potential prognostic and therapeutic implications for TACC3 in glioma management.